HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Baardman Selected Research

lefradafiban

4/2001Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.
12/2000Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Baardman Research Topics

Disease

2Hemorrhage
04/2001 - 12/2000
1Coronary Artery Disease (Coronary Atherosclerosis)
04/2001
1Stable Angina
04/2001
1Neutropenia
12/2000
1Acute Coronary Syndrome
12/2000
1Cardiovascular Diseases (Cardiovascular Disease)
12/2000
1Unstable Angina
12/2000
1Myocardial Infarction
12/2000

Drug/Important Bio-Agent (IBA)

2Glycoproteins (Glycoprotein)IBA
04/2001 - 12/2000
2lefradafibanIBA
04/2001 - 12/2000
1fradafibanIBA
04/2001
1Platelet Membrane GlycoproteinsIBA
04/2001
1Platelet Membrane Glycoprotein IIbIBA
12/2000
1TroponinIBA
12/2000
1Fibrinogen ReceptorsIBA
12/2000

Therapy/Procedure

1Punctures
04/2001